More interestingly, many inhibitory immune checkpoint genes, such as CTLA4, PD-1, and PD-L2, were upregulated in the SOH subgroup, suggesting that YAP1/TAZ may induce resistance of cancer cells to host immune response in GBM (Figure 5). The gene discussed is YAP1; the disease is glioblastoma.